Comments
Suven Life Sciences, a Hyderabad-based bio-pharmaceutical company, has announced it is taking part in the JP Morgan Healthcare Conference 2011 being hosted at San Francisco, US, during January 10-13 and explore option to raise fund and partner with other companies. Mr Venkat Jasti, Chief Executive Officer of Suven, in a statement said that the company will discuss plans for fund raising and potential tie-ups for its phase-2 ready clinical candidate for cognition in Alzheimer's and Schizophrenia. The company has 12 internally discovered therapeutic drug candidates currently in pre-clinical stage of development targeting conditions such as dementia, depression and obesity among others, according to a company statement.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.